IP Library Granted Patent US 10,760,124
Granted Patent B2
US 10,760,124 · App. 15/832,547 · Granted Sep 1, 2020

Methods and systems for processing polynucleotides

Inventors: Benjamin Hindson (Pleasanton, CA); Christopher Hindson (Pleasanton, CA); Michael Schnall-Levin (San Francisco, CA); Kevin Ness (Pleasanton, CA); Mirna Jarosz (Mountain View, CA); Serge Saxonov (Oakland, CA); Paul Hardenbol (San Francisco, CA); Rajiv Bharadwaj (Pleasanton, CA); Xinying Zheng (Mountain View, CA); Phillip Belgrader (Livermore, CA)
Assignee: 10X GENOMICS, INC.
C12Q1/6874C12Q1/683C12Q1/6804C12Q1/6806C12Q2525/191C12Q2535/122C12Q2537/143C12Q2537/149C12Q2563/149C12Q2563/159C12Q2563/179C12Q2565/629
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,760,124
App. No.
15/832,547
Granted
Sep 1, 2020
Kind
B2
Abstract

The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing. Such polynucleotide processing may be useful for a variety of applications, including polynucleotide sequencing.

Claims (73)

1. A composition comprising: a support comprising a nucleic acid barcode molecule coupled thereto, wherein said nucleic acid barcode molecule comprises (i) a barcode sequence, and (ii) a template switching sequence, wherein said template switching sequence of said nucleic acid barcode molecule is configured to capture a complementary deoxyribonucleic acid (cDNA) molecule from solution and facilitate a template switching reaction of said cDNA molecule onto said nucleic acid barcode molecule as a template, which cDNA molecule is derived from a ribonucleic acid (RNA) molecule.

2. The composition of claim 1 , wherein said template switching sequence is a 3′ terminal template switching sequence.

3. The composition of claim 1 , wherein said nucleic acid barcode molecule further comprises a primer or primer binding sequence.

4. The composition of claim 3 , wherein said primer or primer binding sequence is a sequencing primer or sequencing primer binding sequence.

5. The composition of claim 1 , wherein said template switching sequence comprises a poly-nucleotide sequence at a 3′ terminus.

6. The composition of claim 1 , wherein said template switching sequence comprises a poly-guanine (polyG) sequence at said 3′ terminus of said nucleic acid barcode molecule.

7. The composition of claim 6 , wherein said polyG sequence comprises a ribonucleic acid base.

8. The composition of claim 1 , wherein said template switching sequence is between about 6 nucleotides and about 20 nucleotides in length.

9. A composition comprising: a support comprising a plurality of nucleic acid barcode molecules coupled thereto, wherein a nucleic acid barcode molecule of said plurality of nucleic acid barcode molecules comprises (i) a barcode sequence, and (ii) a template switching sequence, wherein said template switching sequence of said nucleic acid barcode molecule is configured to capture a complementary deoxyribonucleic acid (cDNA) molecule from solution and facilitate a template switching reaction of said cDNA molecule onto said nucleic acid barcode molecule as a template, which cDNA molecule is derived from a ribonucleic acid (RNA) molecule.

10. The composition of claim 9 , wherein said nucleic acid barcode molecule further comprises a unique molecular sequence that varies across individual molecules of said plurality of nucleic acid barcode molecules.

11. The composition of claim 10 , wherein said unique molecular sequence is a random N-mer.

12. The composition of claim 9 , wherein said plurality of nucleic acid barcode molecules comprises 100,000 nucleic acid barcode molecules.

13. The composition of claim 9 , wherein said plurality of nucleic acid barcode molecules comprises 1,000,000 nucleic acid barcode molecules.

14. The composition of claim 1 , wherein said nucleic acid barcode molecule is covalently linked to said support.

15. The composition of claim 14 , wherein said nucleic acid barcode molecule is coupled to said support through a disulfide linker.

16. The composition of claim 1 , wherein said support comprises a cystamine or a modified cystamine.

17. The composition of claim 1 , wherein said support is covalently linked to said plurality of nucleic acid barcode molecules through a cleavable linkage.

18. The composition of claim 17 , wherein said cleavable linkage is one or more members selected from the group consisting of a chemically cleavable linkage, a photocleavable linkage, and a thermally cleavable linkage.

19. The composition of claim 1 , wherein said support is a bead.

20. The composition of claim 19 , wherein said bead is a gel bead.

21. The composition of claim 20 , wherein said gel bead is degradable upon application of a stimulus.

22. The composition of claim 21 , wherein said stimulus is a chemical stimulus or a photo stimulus.

23. The composition of claim 21 , wherein said gel bead comprises cross-links and wherein said stimulus is a chemical stimulus that cleaves said cross-links.

24. The composition of claim 20 , wherein said gel bead comprises disulfide cross-links.

25. The composition of claim 20 , wherein said nucleic acid barcode molecule is coupled to said gel bead through a disulfide linker.

26. A composition comprising: a gel bead comprising 100,000 nucleic acid barcode molecules releasably attached thereto, wherein a nucleic acid barcode molecule of said 100,000 nucleic acid barcode molecules comprises (i) a primer or primer binding sequence, (ii) a barcode sequence, (iii) a random N-mer sequence, and (iv) a template switching sequence configured to facilitate a template switching reaction of a complementary deoxyribonucleic acid (cDNA) molecule derived from a ribonucleic acid (RNA) molecule.

27. The composition of claim 26 , wherein said template switching sequence comprises a 3′ terminal polyG sequence, wherein said polyG sequence comprises a ribonucleic acid base.

28. The composition of claim 26 , wherein said gel bead comprises disulfide cross-links.

29. The composition of claim 26 , wherein said nucleic acid barcode molecule is coupled to said gel bead through a disulfide linker.

30. The composition of claim 26 , further comprising a plurality of gel beads, including said gel bead, wherein said plurality of gel beads comprise a plurality of barcode sequences, including said barcode sequence, wherein said barcode sequence is different than other barcode sequences of other gel beads of said plurality of gel beads.

31. The composition of claim 9 , wherein said template switching sequence is a 3 ′ terminal template switching sequence.

32. The composition of claim 9 , wherein said nucleic acid barcode molecule further comprises a primer or primer binding sequence.

33. The composition of claim 32 , wherein said primer or primer binding sequence is a sequencing primer or sequencing primer binding sequence.

34. The composition of claim 9 , wherein said template switching sequence comprises a poly-nucleotide sequence at a 3′ terminus.

35. The composition of claim 9 , wherein said template switching sequence comprises a poly-guanine (polyG) sequence at said 3′ terminus of said nucleic acid barcode molecule.

36. The composition of claim 35 , wherein said polyG sequence comprises a ribonucleic acid base.

37. The composition of claim 9 , wherein said template switching sequence is between about 6 nucleotides and about 20 nucleotides in length.

38. The composition of claim 9 , wherein said nucleic acid barcode molecule is covalently linked to said support.

39. The composition of claim 38 , wherein said nucleic acid barcode molecule is coupled to said support through a disulfide linker.

40. The composition of claim 9 , wherein said support comprises a cystamine or a modified cystamine.

41. The composition of claim 9 , wherein said support is covalently linked to said plurality of nucleic acid barcode molecules through a cleavable linkage.

42. The composition of claim 41 , wherein said cleavable linkage is one or more members selected from the group consisting of a chemically cleavable linkage, a photocleavable linkage, and a thermally cleavable linkage.

43. The composition of claim 9 , wherein said support is a bead.

44. The composition of claim 43 , wherein said bead is a gel bead.

45. The composition of claim 44 , wherein said gel bead is degradable upon application of a stimulus.

46. The composition of claim 45 , wherein said stimulus is a chemical stimulus or a photo stimulus.

47. The composition of claim 45 , wherein said gel bead comprises cross-links and wherein said stimulus is a chemical stimulus that cleaves said cross-links.

48. The composition of claim 44 , wherein said gel bead comprises disulfide cross-links.

49. The composition of claim 44 , wherein said nucleic acid barcode molecule is coupled to said gel bead through a disulfide linker.

50. The composition of claim 9 , further comprising said RNA molecule.

51. The composition of claim 9 , further comprising a partition comprising said support.

52. The composition of claim 51 , wherein said partition is a droplet among a plurality of droplets.

53. The composition of claim 51 , wherein said partition is a well among a plurality of wells.

54. The composition of claim 9 , further comprising a reverse transcriptase that is configured to generate said cDNA molecule from said RNA molecule.

55. The composition of claim 54 , wherein said reverse transcriptase has terminal transferase activity and is configured to template switch onto said nucleic acid barcode molecule as said template.

56. The composition of claim 26 , wherein said primer or primer binding sequence is a sequencing primer or sequencing primer binding sequence.

57. The composition of claim 26 , wherein said template switching sequence is between about 6 nucleotides and about 20 nucleotides in length.

58. The composition of claim 26 , wherein said gel bead comprises a cystamine or a modified cystamine.

59. The composition of claim 26 , wherein said 100,000 nucleic acid barcode molecules are releasably attached to said gel bead via a cleavable linkage, wherein said cleavable linkage comprises one or more members selected from the group consisting of a chemically cleavable linkage, a photocleavable linkage, and a thermally cleavable linkage.

60. The composition of claim 26 , wherein said gel bead is degradable upon application of a stimulus.

61. The composition of claim 60 , wherein said stimulus is a chemical stimulus or a photo stimulus.

62. The composition of claim 26 , further comprising said RNA molecule.

63. bThe composition of claim 26 , further comprising a partition comprising said gel bead.

64. The composition of claim 63 , wherein said partition is a droplet among a plurality of droplets.

65. The composition of claim 63 , wherein said partition is a well among a plurality of wells.

66. The composition of claim 26 , further comprising a reverse transcriptase that is configured to generate said cDNA molecule from said RNA molecule.

67. The composition of claim 65 , wherein said reverse transcriptase has terminal transferase activity and is configured to template switch onto said nucleic acid barcode molecule.

68. The composition of claim 1 , further comprising said RNA molecule.

69. The composition of claim 1 , further comprising a partition comprising said support.

70. The composition of claim 69 , wherein said partition is a droplet among a plurality of droplets.

71. The composition of claim 69 , wherein said partition is a well among a plurality of wells.

72. The composition of claim 1 , further comprising a reverse transcriptase that is configured to generate said cDNA molecule from said RNA molecule.

73. The composition of claim 72 , wherein said reverse transcriptase has terminal transferase activity and is configured to template switch onto said nucleic acid barcode molecule as said template.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2020
From: HINDSON, BENJAMIN; HINDSON, CHRISTOPHER; SCHNALL-LEVIN, MICHAEL; NESS, KEVIN; JAROSZ, MIRNA; SAXONOV, SERGE; HARDENBOL, PAUL; BHARADWAJ, RAJIV; ZHENG, XINYING; BELGRADER, PHILLIP
To: 10X GENOMICS, INC.
Reel/Frame 052600/0834 →
Continuity (5)
Continuation 15717871 · Sep 27, 2017
Continuation In Part 14752641 · Jun 26, 2015
Provisional Application 62061567 · Oct 8, 2014
Provisional Application 62017558 · Jun 26, 2014
Related Publication 20180094315A1 · Apr 5, 2018
Cited By (1)
US 12,312,640